ArticleAnnals of the rheumatic diseases2023

Response to: 'Correspondence on 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement'' by Banday

Peter Nash et al.PubMed ↗Publisher ↗

No numbers read from the abstract.